학술논문

Late‐onset retinal degeneration pathology due to mutations in CTRP5 is mediated through HTRA1
Document Type
article
Source
Aging Cell. 18(6)
Subject
Biomedical and Clinical Sciences
Ophthalmology and Optometry
Neurosciences
Eye Disease and Disorders of Vision
Biotechnology
Neurodegenerative
Aetiology
2.1 Biological and endogenous factors
Eye
Animals
Cellular Senescence
Collagen
High-Temperature Requirement A Serine Peptidase 1
Humans
Mass Spectrometry
Mice
Mutation
Retinal Degeneration
age-related macular degeneration
CTRP5
drusen
ECM remodeling
HTRA1
L-ORD
sub-RPE deposits
Biological Sciences
Medical and Health Sciences
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Language
Abstract
Late-onset retinal degeneration (L-ORD) is an autosomal dominant macular degeneration characterized by the formation of sub-retinal pigment epithelium (RPE) deposits and neuroretinal atrophy. L-ORD results from mutations in the C1q-tumor necrosis factor-5 protein (CTRP5), encoded by the CTRP5/C1QTNF5 gene. To understand the mechanism underlying L-ORD pathology, we used a human cDNA library yeast two-hybrid screen to identify interacting partners of CTRP5. Additionally, we analyzed the Bruch's membrane/choroid (BM-Ch) from wild-type (Wt), heterozygous S163R Ctrp5 mutation knock-in (Ctrp5S163R/wt ), and homozygous knock-in (Ctrp5S163R/S163R ) mice using mass spectrometry. Both approaches showed an association between CTRP5 and HTRA1 via its C-terminal PDZ-binding motif, stimulation of the HTRA1 protease activity by CTRP5, and CTRP5 serving as an HTRA1 substrate. The S163R-CTRP5 protein also binds to HTRA1 but is resistant to HTRA1-mediated cleavage. Immunohistochemistry and proteomic analysis showed significant accumulation of CTRP5 and HTRA1 in BM-Ch of Ctrp5S163R/S163R and Ctrp5S163R/wt mice compared with Wt. Additional extracellular matrix (ECM) components that are HTRA1 substrates also accumulated in these mice. These results implicate HTRA1 and its interaction with CTRP5 in L-ORD pathology.